Episode Thumbnail
Episode 46  |  32:18 min

Understanding FDA’s Proposed Conformity Assessment Pilot Program

Episode 46  |  32:18 min  |  11.07.2019

Understanding FDA’s Proposed Conformity Assessment Pilot Program

00:00
00:00
This is a podcast episode titled, Understanding FDA’s Proposed Conformity Assessment Pilot Program. The summary for this episode is: Today on the Global Medical Device Podcast, we’ll be talking to Mike Drues, who is a frequent guest on our show. He’s the president of Vascular Sciences and a guru on all things related to regulatory compliance for medical device companies. We’ll be chatting about a new program that’s just been announced. It’s a pilot program on accrediting test organizations. The potential is that test compliance will be more consistent and that the process will be streamlined. Some of the highlights of the show include: ● The background of the Accreditation Scheme for Conformity Assessment (ASCA): When it came about, when it should be implemented, and what it’s going to be used for. ● How current politics have impacted the development of this new program. ● Some of the challenges that the ASCA will likely bring about. ● The importance of asking the right questions and running the right tests. ● Thoughts on what to do if a regulation or a particular type of test is not appropriate or not possible. ● The potential pitfalls of putting testing labs into a position where conflict of interest is a real concern.
Today on the Global Medical Device Podcast, we’ll be talking to Mike Drues, who is a frequent guest on our show. He’s the president of Vascular Sciences and a guru on all things related to regulatory compliance for medical device companies. We’ll be chatting about a new program that’s just been announced. It’s a pilot program on accrediting test organizations. The potential is that test compliance will be more consistent and that the process will be streamlined. Some of the highlights of the show include: ● The background of the Accreditation Scheme for Conformity Assessment (ASCA): When it came about, when it should be implemented, and what it’s going to be used for. ● How current politics have impacted the development of this new program. ● Some of the challenges that the ASCA will likely bring about. ● The importance of asking the right questions and running the right tests. ● Thoughts on what to do if a regulation or a particular type of test is not appropriate or not possible. ● The potential pitfalls of putting testing labs into a position where conflict of interest is a real concern.

More Episodes

Focusing on the Intent of the UDI Requirements from FDA's Final Guidance Doc

Addressing the 'Who, What, When' of Quality in the Medical Device Industry

Meet a Guru: Maryann Mitchell

Why Storytelling Matters for Medical Device Companies

A Breakthrough Device that Aims to Prevent Osteoporosis

Understanding FDA's New Intended Use Rule and its Implications